Orange Book product · Generic (ANDA)
BROMOCRIPTINE MESYLATE
BROMOCRIPTINE MESYLATE
At a glance
Apr 04, 2005
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 04, 2005
21 yr 6 mo ago
Today
Pharmaceutical detail
Active ingredient
BROMOCRIPTINE MESYLATE
Strength
EQ 5MG BASE
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 077226
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of BROMOCRIPTINE MESYLATE
- 2009CYCLOSETBrand (NDA)
NDA 020866 · VEROSCIENCE
- 1982PARLODELBrand (NDA)
NDA 017962 · ESJAY PHARMA
- 2008BROMOCRIPTINE MESYLATEGeneric (ANDA)
ANDA 077646 · PADAGIS US
- 2008BROMOCRIPTINE MESYLATEGeneric (ANDA)
ANDA 078899 · ZYDUS PHARMS USA INC
- 2004BROMOCRIPTINE MESYLATEGeneric (ANDA)
ANDA 076962 · AUROBINDO PHARMA USA
- 1998BROMOCRIPTINE MESYLATEGeneric (ANDA)
ANDA 075100 · LEK PHARM
- 1998BROMOCRIPTINE MESYLATEGeneric (ANDA)
ANDA 074631 · SANDOZ
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
